SARCOMA, EWING
Clinical trials for SARCOMA, EWING explained in plain language.
Never miss a new study
Get alerted when new SARCOMA, EWING trials appear
Sign up with your email to follow new studies for SARCOMA, EWING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat childhood bone cancer
Disease control OngoingThis study is testing whether adding a drug called abemaciclib to standard chemotherapy (irinotecan and temozolomide) is better at controlling Ewing's sarcoma that has returned or stopped responding to treatment. It involves about 46 children and young adults. The main goal is to…
Matched conditions: SARCOMA, EWING
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for young cancer patients: experimental drug targets tumors
Disease control TerminatedThis study is testing whether a new drug called PEN-866, when combined with two standard chemotherapy drugs (vincristine and temozolomide), can help control aggressive cancers that have returned or not responded to other treatments. It is for adolescents and young adults (ages 12…
Matched conditions: SARCOMA, EWING
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC